Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Beam Therapeutics Inc. (BEAM), most recent 12 months reported: revenue $156.03M, net loss $85.43M, free cash flow -$372.77M. Latest balance sheet on file: liquid cash $1.15B, total debt $100.26M, net cash $1.05B. From SEC filings. More on Beam Therapeutics Inc.: Revenue · Profitability · Cash flow · Debt Others in Biological Products, (No Diagnostic Substances): Vir Biotechnology, Inc. · Vaxart, Inc. · REGENXBIO Inc. · IMMUNITYBIO, INC. · AGENUS INC · ATARA BIOTHERAPEUTICS, INC. · Autolus Therapeutics plc · GINKGO BIOWORKS HOLDINGS, INC.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.